Literature DB >> 8604026

Ceramide selectively inhibits early events in the response of human neutrophils to tumor necrosis factor.

M Fuortes1, W Jin, C Nathan.   

Abstract

Cell spreading and the respiratory burst of neutrophils responding to soluble, physiological agents and adherent to model biological surfaces are typically delayed in onset by 15 min or more. The lag period may be a physiologically important feature of the action of such agents on neutrophils in that it may allow for migration before secretion. However, the mechanism that interposes such a long delay between stimulus and response is unknown. Tumor necrosis factor alpha (TNF-alpha) mediates some of its actions by triggering sphingomyelinase to generate ceramide. In adherent human neutrophils, however, exogenous ceramide did not mimic TNF-alpha's ability to stimulate cell spreading, paxillin tyrosine phosphorylation, or the respiratory burst. On the contrary, ceramide suppressed each such response. Ceramide did so by extending the lag period in the cells' response to TNF-alpha. Ceramide extended the lag period whether it was added exogenously or generated endogenously by sphingomyelinase, and the effect was reversible. Remarkably, however, ceramide inhibited cell spreading or the respiratory burst only if added together with TNF-alpha or within the next few minutes. Neutrophils ignored ceramide if it was added later, even if the TNF-alpha-triggered respiratory burst had not yet commenced. These features suggest that an early, brief elevation of ceramide in response to TNF-alpha could mediate the lag period. By temporarily inhibiting tyrosine phosphorylation, cell spreading, and the respiratory burst, ceramide or a functionally similar mediator could serve as a phase coordinator of the neutrophil's response to soluble agonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604026     DOI: 10.1002/jlb.59.3.451

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

2.  An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.

Authors:  Robert G Sitrin; Timothy M Sassanella; Howard R Petty
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-08       Impact factor: 6.914

3.  A novel sphingomyelinase-like enzyme in Ixodes scapularis tick saliva drives host CD4 T cells to express IL-4.

Authors:  F J Alarcon-Chaidez; V D Boppana; A T Hagymasi; A J Adler; S K Wikel
Journal:  Parasite Immunol       Date:  2009-04       Impact factor: 2.280

Review 4.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

5.  Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide.

Authors:  Yan Sun; Todd Fox; Gautam Adhikary; Mark Kester; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2008-04-17       Impact factor: 4.962

6.  HMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactions.

Authors:  Chen Wang; Dong-Yuan Chang; Min Chen; Ming-Hui Zhao
Journal:  J Cell Mol Med       Date:  2017-02-09       Impact factor: 5.310

7.  Critical role of the carboxyl terminus of proline-rich tyrosine kinase (Pyk2) in the activation of human neutrophils by tumor necrosis factor: separation of signals for the respiratory burst and degranulation.

Authors:  Hyunsil Han; Michele Fuortes; Carl Nathan
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

8.  Effects of sphingosine and sphingosine analogues on the free radical production by stimulated neutrophils: ESR and chemiluminescence studies.

Authors:  A Mouithys-Mickalad; G Deby-Dupont; M Hoebeke; M Mathy-Hartert; M Lamy; C Deby
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.